COMMUNIQUÉS West-GlobeNewswire

HelpAlert Launches Elderly Welfare Check-In App in the United States That Requires No Wearable Device And Is Very Simple To Use.
26/02/2026
Voice-based system delivers automated daily welfare calls and smart escalation alerts using existing landline or mobile phones Los Angeles, CALIFORNIA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- HelpAlert , an elderly welfare [...]
FDA approves HERNEXEOS®, the first targeted therapy for adults with HER2-mutant advanced NSCLC as an initial treatment option
26/02/2026
This press release is not intended for UK media HERNEXEOS ® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as demonstrated in the Beamion LUNG-1 clinical trial 1 Accelerated approval [...]
Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high‑growth nutraceutical ingredients across EMEA
26/02/2026
Regulated information – inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 February 2026 – 6:30PM Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high ‑ [...]
USOSM Commends Surgeon Partner Dr. Wendy Liao on Her Medical Mission Work in The Philippines
26/02/2026
Team Provided Pro Bono Dental care to 1,739 Students IRVING, Texas and ALAMEDA, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) salutes its surgeon partner Wendy Liao, DDS, as she [...]
Curium Announces Pharmacokinetics and Dosimetry Data for Investigational Lutetium-177 Zadavotide Guraxetan in Metastatic Castration-Resistant Prostate Cancer at ASCO GU 2026
26/02/2026
Dosimetry data from the Phase 3 ECLIPSE substudy demonstrated favorable organ radiation absorbed doses supporting administration of 7.4 GBq for up to six cycles BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Curium, a world [...]
Longevity Supplement Primeadine® GF Named 2026 NEXTY Award Finalist by New Hope Network
26/02/2026
Gluten-Free, Whole-Food Spermidine Formula Recognized as One of Only Six Finalists in the Supplements for the Body Category SHERIDAN, Wyo., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Oxford Healthspan is excited to announce that [...]
Flourish Research® Announces Strategic Partnership with Capitol Imaging Services and Upcoming Launch of Flourish Imaging™ in Gainesville, Georgia
26/02/2026
APEX, N.C., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Flourish Research ® today announced a strategic partnership with Capitol Imaging Services in advance of the launch of Flourish Imaging™, an advanced imaging center currently [...]
AMN Healthcare Survey Reveals Sharp Divide Between Leaders’ Organizational Confidence and Industry Outlook for 2026
26/02/2026
Survey of 700+ executives shows AI leadership roles surging as succession planning and clinician engagement lag DALLAS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- While nearly three-quarters of healthcare executives believe [...]
GENFIT : Information financière du quatrième trimestre 2025 et point sur les activités de la Société
26/02/2026
Trésorerie et équivalents de trésorerie s’élevant à 101,1 millions d’euros au 31 décembre 2025 Revenus s’élevant à 65,4 millions d’euros pour l’exercice 2025 Solide performance d’Iqirvo® d’Ipsen dans la PBC (> USD [...]
CurePSP Explains Progressive Supranuclear Palsy After Rev. Jesse L. Jackson’s Passing
26/02/2026
NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The passing of Rev. Jesse L. Jackson, Sr. has cast a spotlight on progressive supranuclear palsy (PSP), one of the most misunderstood neurodegenerative diseases affecting [...]
BeautyHealth to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
26/02/2026
LONG BEACH, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report fourth quarter and full year 2025 financial results [...]
Trading by management and close relations of management
26/02/2026
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the [...]
Full-year 2025 results
26/02/2026
Solid 2025 results Debt reduction trajectory confirmed Growth objectives for 2025-2028 All tables are available in the PDF. Successful plan to strengthen the financial position and confirmed debt reduction trajectory: [...]
OSE Immunotherapeutics reçoit un deuxième avis positif du Comité Indépendant de Surveillance des Données (IDMC) pour l’essai pivot de Phase 3 ARTEMIA évaluant Tedopi® dans le cancer du poumon non à petites cellules
26/02/2026
Nantes, le 26 février 2026 – 18h00 CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo : OSE) annonce aujourd’hui que le Comité Indépendant de Surveillance des Données (IDMC) a émis une deuxième recommandation [...]
Résultats annuels 2025
26/02/2026
Résultats 2025 solides Trajectoire de désendettement confirmée Objectifs de croissance à horizon 2028 L’ensemble des tableaux sont disponibles dans le PDF Succès du plan de renforcement de la structure financière et [...]
OSE Immunotherapeutics Receives Second Positive IDMC Recommendation for Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer
26/02/2026
NANTES, France, February 26, 2026 – 6pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , today announced that the Independent Data Monitoring Committee (IDMC) has issued a second positive [...]
GENFIT Reports Fourth Quarter 2025 Financial Information and Provides a Corporate Update
26/02/2026
Cash and cash equivalents totaled €101.1 million as of December 31, 2025 Revenues amounted to €65.4 million as of December 31, 2025 Ipsen’s strong performance with Iqirvo® in PBC (>$200M net sales in year one) [...]
Regeneron Renews Sponsorship of the Regeneron Science Talent Search Through 2036, Committing an Additional $150 Million to Empower the Next Generation of Science and Technology Leaders
26/02/2026
Key Takeaways: Regeneron will extend its title sponsorship of the Regeneron Science Talent Search (STS) for a second decade, continuing its partnership with Society for Science to support the United States’ oldest and [...]
Regeneron Renews Sponsorship of the Regeneron Science Talent Search Through 2036, Committing an Additional $150 Million to Empower the Next Generation of Science and Technology Leaders
26/02/2026
Key Takeaways: Regeneron will extend its title sponsorship of the Regeneron Science Talent Search (STS) for a second decade, continuing its partnership with Society for Science to support the United States’ oldest and [...]

Pages